Magazine Article | December 1, 2020

Can Your CDMO Relationships Survive Another "Virtual" Year?

Source: Life Science Leader

By Louis Garguilo, Chief Editor, Outsourced Pharma

“I spent five years in Kalamazoo, right out of college, working for Upjohn, now Pfizer of course, because it was Pfizer-ed, and I do use that as a verb. So, it’s suddenly been 25 years in various parts of the industry dealing with outsourcing, but, then again, I have a child who’s turning 20 in a week and a half. So there’s that.”

And that’s Lori Hoffman. A unique communicator who hasn’t slowed a syllable since we first met at a CDMO circa 2005. Since then, she’s worked at a second CDMO, but mostly her career has been on the other side of the outsourcing equation, managing relationships with external development and manufacturing partners. In July, she joined Slayback Pharma as Head of alliance management. Slayback is a privately held, specialty pharma based in Princeton, NJ, with formulation development operations in Hyderabad, India. Her role covers working with some 20 external partners manufacturing a large portfolio of products. So it makes perfect sense that when I ask her how the current year of pandemic pandemonium has changed the outsourcing industry — and might continue into our future — she focuses on communication.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader